Hydroxyurea corrects the dysregulated L-selectin expression and increased H2O2 production of polymorphonuclear neutrophils from patients with sickle cell anemia

Blood

Volumn 99, Issue 7, 2002, Pages 2297-2303

  Benkerrou, Malika ^a,b   Delarche, Charlotte ^a,b   Brahimi, Lamia ^a,b   Fay, Michèle ^b   Vilmer, Etienne ^a,b   Elion, Jacques ^a,b   Gougerot Pocidalo, Marie Anne ^a,b   Elbim, Carole ^a,b  

^a BICHAT HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HYDROGEN PEROXIDE; HYDROXYUREA; SELECTIN;

ADOLESCENT; ARTICLE; BIOSYNTHESIS; BLOOD VESSEL OCCLUSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY BURST; SICKLE CELL ANEMIA;

EID: 0036530221     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.7.2297     Document Type: Article

References (58)

1. Pain in sickle cell disease - Rates and risk factors
2. Adhesive interactions of sickle erythrocytes with endothelium
3. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice
4. Effect of hydroxyurea on frequency of painful crises in sickle cell anemia
5. Longterm hydroxyurea treatment in young sickle cell patients
6. - sickle reticulocytes to endothelial cells
7. Activated monocytes in sickle cell disease: Potential role in the activation of vascular endothelium and vaso-occlusion
8. Mortality in sickle cell disease: Life expectancy and risk factors for early death
9. Prediction of adverse outcomes in children with sickle cell disease
10. Hydroxyurea therapy for diverse pediatric populations with sickle cell disease
11. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults
12. Leukocyte adhesion deficiency: An inherited defect in the Mac-1, LFA-1, and p150-95 glycoproteins
13. Selectins
14. Oxidants from phagocytes: Agents of defense and destruction
15. Leukocyte-endothelial interactions
16. Oxygen free radicals linked to many diseases
17. α4β1-integrin expression on sickle reticulocytes: Vascular cell adhesion molecule-1-dependent binding to endothelium
18. Perfusion with sickle erythrocytes up-regulates ICAM-1 and VCAM-1 gene expression in cultured human endothelial cells
19. Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst
20. Abnormal neutrophil adhesion in sickle cell anaemia and crisis: Relationship to blood theology
21. The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia
22. Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64
23. 2 in sickle cell disease
24. Neutrophil activation in sickle cell disease
25. Effects of cell purification methods on CD11b and L-selectin expression as well as the adherence and activation of leukocytes
26. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro
27. Interaction of endothelial cells and neutrophils in vitro: Kinetics of thrombomodulin, intercellular adhesion molecule-1 (ICAM-1), E-selectin, and vascular cell adhesion molecule-1 (VCAM-1): Implications for the relevance as serological disease activity markers in vasculitides
28. Role of selectins in development of adult respiratory distress syndrome
29. Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation
30. Priming of polymorphonuclear neutrophils by tumor necrosis factor α in whole blood: Identification of two polymorphonuclear neutrophil subpopulations in response to formyl-peptides
31. Polymorphonuclear neutrophils from human immunodeficiency virus-infected patients show enhanced activation, diminished fMLP-induced L-selectin shedding, and an impaired oxidative burst after cytokine priming
32. Differential surface expression of cell adhesion molecules during granulocyte maturation
33. Differential priming effects of proinflammatory cytokines on human neutrophil oxidative burst in response to bacterial N-formyl peptides
34. Human endothelial cells regulate polymorphonuclear leukocyte degranulation
35. Neutrophil dysfunctions, IL-8, and soluble L-selectin plasma levels in rapidly progressive versus adult and localized juvenile periodontitis: Variations according to disease severity and microbial flora
36. Blood neutrophil functions and cytokine release in severe alcoholic hepatitis: Effect of corticosteroids
37. Sulfhydryl regulation of L-selectin shedding: Phenylarsine oxide promotes activation-independent L-selectin shedding from leukocytes
38. L-selectin shedding regulates leukocyte recruitment
39. Potentiation of the oxidative burst of human neutrophils. A signaling role for L-selectin
40. Acute phase proteins and interleukins in steady state sickle cell disease
41. Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis
42. Tumor necrosis factor-alpha is undetectable in the plasma of SS patients with elevated HbF
43. Platelet-activating factor in plasma of patients with sickle cell disease in steady state
44. Activation of the alternative complement pathway by exposure of phosphatidylserine on erythrocytes from sickle cell disease patients
45. Complement activation during painful crisis in sickle cell anemia
46. Elevated levels of circulating molecules of potential endothelial origin in sickle cell disease [abstract]
47. Localization of ligands for L-selectin in mouse peripheral lymph node high endothelial cells by colloidal gold conjugates
48. The effect of trauma on neutrophil L-selectin expression and L-selectin serum levels
49. Circulating activated endothelial cells in sickle cell anemia
50. Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis
51. Cytokines and soluble adhesion molecules in sickle cell anemia patients during hydroxyurea therapy
52. Sickle reticulocytes adhere to VCAM-1
53. Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia
54. Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients
55. A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy
56. Chemiluminescence from human polymorphonuclear leukocytes activated with opsonized zymosan